Acadia Pharmaceuticals Has Returned 25.7% Since SmarTrend Recommendation (ACAD)
March 15, 2017 at 14:02 PM EDT
SmarTrend identified an Uptrend for Acadia Pharmaceuticals (NASDAQ:ACAD) on December 27th, 2016 at $29.93. In approximately 3 months, Acadia Pharmaceuticals has returned 25.67% as of today's recent price of...